SNAP Participation and Medication Adherence Among Older Black Medicaid-Insured Individuals Living With Hypertension
American Journal of Hypertension · 2023
DOI: 10.1093/ajh/hpad052 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2023. Verfasst von Chinedum O Ojinnaka und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Solutions, Arizona State University, 550 North 3rd Street, Phoenix, Arizona 85004. Hauptthemen laut MEDLINE: Food Assistance, Hypertension, Medication Adherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: U.S. Department of Agriculture, University of Kentucky Center.
Abstract (Originalsprache)
BACKGROUND Black people are more likely to be diagnosed with hypertension and to experience food insecurity and antihypertensive medication non-adherence compared to White people in the U.S. The Supplemental Nutrition Assistance Program (SNAP)—a means-tested program that targets food insecurity has been shown to affect health outcomes. This study analyzed the relationship between SNAP participation and antihypertensive medication adherence among older Black Medicaid-insured individuals. METHODS This is a retrospective cohort study using linked 2006–2014 state of Missouri Medicaid and SNAP administrative claims data. Analyses were restricted to older (≥60 years) Black individuals who were continuously enrolled in Medicaid for 12 months following their first observed claim for hypertension at or after age 60 years with at least one pharmacy claim (n = 10,693). Our outcome measure is a dichotomous measure of antihypertensive medication adherence defined using the Proportion of Days Covered (≥80% PDC = 1). The exposure variables are four measures of SNAP participation. RESULTS A higher proportion of SNAP participants were adherent to their antihypertensive medications compared to non-SNAP participants (43.5% vs. 32.0%). On multivariable analyses, compared to non-SNAP participants there was an increased likelihood of antihypertensive medication adherence among SNAP participants (prevalence ratio [PR] = 1.25; 95% confidence interval [CI] = 1.16–1.35). Compared to those who participated in SNAP for 1–3 months during the 12-month continuous enrollment, there was an increased likelihood of antihypertensive medication adherence among those who were enrolled for 10–12 months (PR = 1.41; 95% CI = 1.08–1.85). CONCLUSIONS Medicaid-insured older Black adults who were SNAP participants had a higher likelihood of antihypertensive medication adherence compared to non-SNAP participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health Solutions, Arizona State University, 550 North 3rd Street, Phoenix, Arizona 85004.
- Harry S Truman School of Public Affairs, University of Missouri, 239 Middlebush Hall, Columbia, Missouri 65211.
- Economic Research Service, United States Department of Agriculture, PO Box 419205, MS 9999, Kansas City, Missouri 64141-6205.
- Maxwell School of Citizenship and Public Affairs, Syracuse University, 426 Eggers Hall, Syracuse, New York 13244-1020.
Förderung
- U.S. Department of Agriculture
- University of Kentucky Center
Zitieren
APA
Ojinnaka, C. O., Arteaga, I., Hodges, L., & Heflin, C. (2023). SNAP Participation and Medication Adherence Among Older Black Medicaid-Insured Individuals Living With Hypertension. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpad052
Vancouver
Ojinnaka CO, Arteaga I, Hodges L, Heflin C. SNAP Participation and Medication Adherence Among Older Black Medicaid-Insured Individuals Living With Hypertension. American Journal of Hypertension. 2023. doi:10.1093/ajh/hpad052
BibTeX
@article{Ojinnaka2023,
author = {Ojinnaka, Chinedum O and Arteaga, Irma and Hodges, Leslie and Heflin, Colleen},
title = {SNAP Participation and Medication Adherence Among Older Black Medicaid-Insured Individuals Living With Hypertension},
journal = {American Journal of Hypertension},
year = {2023},
doi = {10.1093/ajh/hpad052}
}
EUVIMED